Key statistics
On Friday, Cabaletta Bio Inc (CABA:NSQ) closed at 4.70, 35.40% above the 52 week low of 3.47 set on Aug 08, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.70 |
---|---|
High | 4.76 |
Low | 4.40 |
Bid | 4.22 |
Offer | 5.22 |
Previous close | 4.70 |
Average volume | 1.15m |
---|---|
Shares outstanding | 48.85m |
Free float | 46.75m |
P/E (TTM) | -- |
Market cap | 229.59m USD |
EPS (TTM) | -1.92 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
- Cabaletta Bio to Participate in Upcoming Investor Conferences in September
- Cabaletta Bio Reports Second Quarter 2024 Financial Results and Provides Business Update
- Cabaletta Bio to Participate in the Stifel 2024 Virtual Cell Therapy Forum
- Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis™ and RESET-SLE™ Trials of CABA-201
- Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference
- Cabaletta Bio Reports First Quarter 2024 Financial Results and Provides Business Update
- Cabaletta Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
- Cabaletta Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
- Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Systemic Sclerosis
- Cabaletta Bio to Participate in Upcoming Investor Conferences in March
More ▼